Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
Sthanu Subramanian, Pediatrician, shared a post on X about a recent article by Motoaki Sano et al. published in Journal of Clinical Medicine Research, adding:
“Empagliflozin and a rise in Hematocrit.
The rise in hematocrit beyond simple diuresis in a patient on empagliflozin is primarily driven by enhanced erythropoiesis (increased red blood cell production), rather than just plasma volume contraction.
While diuresis causes a brief, initial spike in hematocrit, the sustained elevation seen over months is a direct result of stimulated erythropoietin (EPO) production.
Clinical Significance.
This dual mechanism – short-term hemoconcentration plus long-term erythropoiesis—typically raises hematocrit by 2% to 4%.
In large clinical trials like EMPA-REG OUTCOME, this increase in hematocrit and hemoglobin was identified as one of the single strongest statistical mediators of the drug’s profound cardiorenal benefits.
It directly improves systemic and myocardial oxygen delivery without increasing the risk of thrombotic events.”
Title: Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys
Authors: Motoaki Sano, Makoto Takei, Yasuyuki Shiraishi, Yoshihiko Suzuki

Other posts featuring Sthanu Subramanian on Hemostasis Today.
-
Oct 8, 2026, 17:00Sally Mandour: Platelet Size And Shape Can Reveal The Diagnosis
-
Oct 8, 2026, 16:49Neil Morgan: Advancing Understanding Of Bleeding Disorders Of Unknown Cause
-
Oct 8, 2026, 16:38Beverley Hunt: Advancing Pulmonary Embolism Care Through Collaboration And Learning
-
Oct 8, 2026, 16:19Cedric Hermans: Six Webinars Advancing Haemophilia Care And Beyond
-
Oct 8, 2026, 16:09Luana Banu: Every Donation Connects A Human Chain
-
Oct 8, 2026, 15:51Khaled Musallam: A New Era In Thalassemia Care
-
Oct 8, 2026, 15:40Juan J. Ortiz։ Catheter Directed Therapy In Pulmonary Embolism
-
Oct 8, 2026, 15:34Petros Kountouris: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 8, 2026, 15:14Renzo Mancuso: Human Stem Cell Model Reveals Progenitor Fate in Tissue Macrophages